Skip to main content

Advertisement

Table 2 Relative frequencies for transitioning from baseline to endpoint category

From: Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients

  Percentage of patients (duloxetine/placebo)  
  Endpoint category  
Baseline category 1 (worst) 2 (physically poor) 3 (mentally poor) 4 (moderate) 5 (best) Total no. of patients
1 (worst) 27.5/42.5** 25.8/17.2* 16.6/22.4 21.0/9.7** 9.2/8.2 229/134
2 (physically poor) 2.9/6.0 30.5/41.7* 7.1/17.2** 36.4/25.8* 23.0/9.3** 239/151
3 (mentally poor) 12.8/10.8 20.6/24.3 13.5/30.6** 36.2/24.3* 17.0/9.9 141/111
4 (moderate) 2.2/3.2 20.4/16.1 3.2/8.1 41.9/50.0 32.3/22.6 93/62
Total no. of patients 90/80 180/123 77/95 225/110 130/50 702/458
  1. *p < 0.05, **p < 0.01 for the between-treatment difference in the incidence of transitioning.